- High-throughput DNA sequencing of WB populations will identify specific drug-PGX marker pairs relevant for WB region and PGX-WB panel will be designed.
- ePGA-WB (electronic pharmacogenomics assistant for Western Balkan) will be developed and implemented as a tool for personalized drug recommendations based on state-of-the-art PGX knowledge on gene-drug-phenotype associations. ePGA-WB will contain modules for health professionals, biomedical researchers and visitors.
- Discovery of novel potential PGX markers relevant for WB will be tested in iPS cells model system , and PGX-WB panel will be upgraded with novel variants.
HORIZON-WIDERA-2021-ACCESS-02- 01, Grant Agreement number: 101059870